Kinomic exploration of temozolomide and radiation resistance in Glioblastoma multiforme xenolines.
Kinomic exploration of temozolomide and radiation resistance in Glioblastoma multiforme xenolines.
复制标题
DOI:
10.1016/j.radonc.2014.04.010
复制
发表时间:
2014-06
期刊:
影响因子:
--
通讯作者:
Willey CD
中科院分区:
文献类型:
--
作者:
Anderson JC;Duarte CW;Welaya K;Rohrbach TD;Bredel M;Yang ES;Choradia NV;Thottassery JV;Yancey Gillespie G;Bonner JA;Willey CD
Glioblastoma multiforme (GBM) represents the most common and deadly primary brain malignancy, particularly due to temozolomide (TMZ) and radiation (RT) resistance. To better understand resistance mechanisms, we examined global kinase activity (kinomic profiling) in both treatment sensitive and resistant human GBM patient-derived xenografts (PDX or “xenolines”). Thirteen orthotopically-implanted xenolines were examined including 8 with known RT sensitivity/resistance, while 5 TMZ resistant xenolines were generated through serial TMZ treatment in vivo. Tumors were harvested, prepared as total protein lysates, and kinomically analyzed on a PamStation®12 high-throughput microarray platform with subsequent upstream kinase prediction and network modeling. Kinomic profiles indicated elevated tyrosine kinase activity associated with the radiation resistance phenotype, including FAK and FGFR1. Furthermore, network modeling showed VEGFR1/2 and c-Raf hubs could be involved. Analysis of acquired TMZ resistance revealed more kinomic variability among TMZ resistant tumors. Two of the five tumors displayed significantly altered kinase activity in the TMZ resistant xenolines and network modeling indicated PKC, JAK1, PI3K, CDK2, and VEGFR as potential mediators of this resistance. GBM xenolines provide a phenotypic model for GBM drug response and resistance that when paired with kinomic profiling identified targetable pathways to inherent (radiation) or acquired (TMZ) resistance.
登录
查看更多内容
影响因子:
3.7
作者:
Brennan C;Momota H;Hambardzumyan D;Ozawa T;Tandon A;Pedraza A;Holland E
通讯作者:
Holland E
DOI:
10.1093/bioinformatics/btp385
发表时间:
2009-09-01
期刊:
Bioinformatics (Oxford, England)
影响因子:
--
作者:
Gold DL;Miecznikowski JC;Liu S
通讯作者:
Liu S
影响因子:
27.4
作者:
Umiċeviċ Mirkov M;Cui J;Vermeulen SH;Stahl EA;Toonen EJ;Makkinje RR;Lee AT;Huizinga TW;Allaart R;Barton A;Mariette X;Miceli CR;Criswell LA;Tak PP;de Vries N;Saevarsdottir S;Padyukov L;Bridges SL;van Schaardenburg DJ;Jansen TL;Dutmer EA;van de Laar MA;Barrera P;Radstake TR;van Riel PL;Scheffer H;Franke B;Brunner HG;Plenge RM;Gregersen PK;Guchelaar HJ;Coenen MJ
通讯作者:
Coenen MJ
影响因子:
45.3
作者:
Hegi, Monika E.;Liu, Lili;Gilbert, Mark R.
通讯作者:
Gilbert, Mark R.
影响因子:
5.7
作者:
Jarboe, John S.;Jaboin, Jerry J.;Willey, Christopher D.
通讯作者:
Willey, Christopher D.